Pulsetech Medical

Company Overview

Snapshot

Founded in January 2024 by Samer Abboud and George Tummer, Pulsetech Medical operates with 1–10 employees. The company has raised $1 million across one funding round.

Business overview

Pulsetech Medical is a neuromodulation startup developing a next-generation, implantable deep brain stimulation system. This closed-loop platform continuously senses brain waves and physiological signals, applies intelligent signal processing, and adapts stimulation to each patient’s state. The technology is designed to go beyond symptomatic relief, aiming to actively slow or halt the progression of serious neurological diseases such as Parkinson’s. The company serves movement-disorder neurologists and functional neurosurgeons treating advanced neurological conditions in hospital settings, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

When was Pulsetech Medical founded?

Pulsetech Medical was founded in January 2024 by co-founders Samer Abboud and George Tummer.

What is Pulsetech Medical's primary focus?

Pulsetech Medical focuses on developing a neuromodulation platform with an implantable deep brain stimulation system designed to slow or halt the progression of neurodegenerative movement disorders like Parkinson’s.

What is the core technology behind Pulsetech Medical's solution?

Pulsetech Medical's core technology is a closed-loop system that continuously senses brain waves and physiological signals, utilizing intelligent signal processing to adapt stimulation to a patient's specific state for more durable restoration of normal brain activity.

Which markets does Pulsetech Medical target?

Pulsetech Medical targets the healthcare market, specifically serving movement-disorder neurologists and functional neurosurgeons who treat advanced neurological conditions in hospital settings.

What is the current product development stage for Pulsetech Medical?

Pulsetech Medical's product is currently in the Research & Development (R&D) stage.